My watch list  

Bloom syndrome

Bloom syndrome
Classification & external resources
ICD-9 757.39
OMIM 210900
DiseasesDB 1505
eMedicine derm/54 
MeSH D001816

Bloom syndrome is a rare inherited disorder characterized by a high frequency of breaks and rearrangements in an affected person's chromosomes, discovered and first described by dermatologist Dr. David Bloom in 1954.[1]



People with Bloom syndrome are much smaller than average, and often have a high-pitched voice and characteristic facial features including a long, narrow face; small lower jaw; and prominent nose and ears. They tend to develop pigmentation changes and dilated blood vessels in the skin, particularly in response to sun exposure. These changes often appear as a butterfly-shaped patch of reddened skin on the face. The skin changes may also affect the hands and arms.

Other features of the disorder may include learning disabilities, mental retardation, chronic lung problems, diabetes, and immune deficiency that leads to recurrent pneumonia and ear infections. Men with Bloom syndrome usually do not produce sperm and, as a result, are unable to father children. Women with the disorder generally experience menopause earlier than usual.

Relationship to cancer

Chromosomal instability in Bloom syndrome results in a high risk of cancer in affected individuals.[2] Affected individuals develop the full range of cancers found in the general population, but the cancers arise unusually early in life. People with Bloom syndrome may be first diagnosed with cancer at about 25 years old.


Mutations in the BLM gene (locus 15q26.1) cause Bloom syndrome. The BLM gene provides instructions for producing a protein called the Bloom (BLM) syndrome protein, which is a member of the DNA helicase family. DNA helicases are enzymes that unwind the two spiral strands of a DNA molecule so that they can be copied. When a cell prepares to divide to form two cells, the chromosomes are duplicated so that each new cell will get a complete set of chromosomes; this replication process involves unwinding the DNA so that it can be copied. The BLM protein is important in maintaining the stability of the DNA during this process. Mutations in the BLM gene alter or reduce the BLM protein's DNA helicase activity, which causes errors in the copying process during replication. As a result, people with Bloom syndrome have a higher frequency of chromosome breakage and rearrangement than unaffected people. This increase in chromosome breakage and rearrangement leads to the signs and symptoms of Bloom syndrome. Another suggestion put forward is that people with Bloom syndrome overproduce the superoxide anion, whose volatility damages the affected person's chromosomes.

Bloom syndrome is inherited in an autosomal recessive fashion. Both parents must be carriers in order for a child to be affected. The carrier frequency in individuals of Eastern European ancestry is about 1/100. If both parents are carriers, there is a one in four, or 25%, chance with each pregnancy for an affected child. Genetic counseling and genetic testing is recommended for families who may be carriers of Bloom syndrome.

See also


  1. ^ Bloom D (1954). "Congenital telangiectatic erythema resembling lupus erythematosus in dwarfs; probably a syndrome entity". A.M.A. American journal of diseases of children 88 (6): 754-8. PMID 13206391.
  2. ^ Amor-Guéret M (2006). "Bloom syndrome, genomic instability and cancer: the SOS-like hypothesis". Cancer Lett. 236 (1): 1–12. doi:10.1016/j.canlet.2005.04.023. PMID 15950375.
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Bloom_syndrome". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE